| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 06/02/2000 | CA2351631A1 Piperidine quaternary salts-ccr-3 receptor antagonists |
| 06/02/2000 | CA2351630A1 Vector |
| 06/02/2000 | CA2351361A1 Gtpase associated proteins |
| 06/02/2000 | CA2350969A1 Compounds having cytokine inhibitory activity |
| 06/02/2000 | CA2350903A1 Pyrrolidine derivatives-ccr-3 receptor antagonists |
| 06/02/2000 | CA2350759A1 Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation |
| 06/02/2000 | CA2350758A1 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation |
| 06/02/2000 | CA2350755A1 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation |
| 06/02/2000 | CA2350753A1 Benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 06/02/2000 | CA2347940A1 Use of core 2 glcnac transferase inhibitors in treating inflammation |
| 05/31/2000 | EP1004578A2 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives |
| 05/31/2000 | EP1003888A2 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 05/31/2000 | EP1003851A2 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 05/31/2000 | EP1003763A1 83 human secreted proteins |
| 05/31/2000 | EP1003748A2 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 05/31/2000 | EP1003744A1 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS |
| 05/31/2000 | EP1003743A1 3,3-disubstituted piperidines as modulators of chemokine receptor activity |
| 05/31/2000 | EP1003729A1 6-azauracil derivatives as il-5 inhibitors |
| 05/31/2000 | EP1003723A1 2-acylaminopropanamines as tachykinin receptor antagonists |
| 05/31/2000 | EP1003713A1 Anthranilic acid analogs |
| 05/31/2000 | EP1003712A1 Anthranilic acid analogs |
| 05/31/2000 | EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 05/31/2000 | EP1003537A1 Et |
| 05/31/2000 | EP1003528A1 Method of enhancing bioavailability of fexofenadine and its derivatives |
| 05/31/2000 | EP1003514A1 Cyclic amine modulators of chemokine receptor activity |
| 05/31/2000 | EP1003509A1 Il-8 receptor antagonists |
| 05/31/2000 | EP1003504A2 Indole derivatives and their use as mcp-1 antagonists |
| 05/31/2000 | EP1003497A1 Il-8 receptor antagonists |
| 05/31/2000 | EP1003486A2 Pharmaceutical compositions containing an effervescent acid-base couple |
| 05/31/2000 | EP1003479A1 Method and compositions for treating late phase allergic reactions and inflammatory diseases |
| 05/31/2000 | EP1003373A1 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
| 05/31/2000 | EP0865428B1 Vitamin d analogues |
| 05/31/2000 | EP0633775B1 Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor |
| 05/31/2000 | DE19955794A1 Pyrrolidin-Derivate-CCR-3-Rezeptor-Antagonisten Pyrrolidine derivatives-CCR-3 receptor antagonists |
| 05/31/2000 | DE19955340A1 CCR-3-Rezeptor-Antagonisten CCR-3 receptor antagonists |
| 05/31/2000 | DE19856475A1 Nichtsteroidale Entzündungshemmer Nonsteroidal anti-inflammatory drugs |
| 05/31/2000 | CN1254558A S-(3-hydroxypropyl)-L-cysteine composition as oral medicine |
| 05/30/2000 | US6069162 Indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production |
| 05/30/2000 | US6069156 Indole derivatives as cGMP-PDE inhibitors |
| 05/30/2000 | US6069135 Use of hyaluronic acid or its derivatives to enhance delivery of therapeutic agents |
| 05/30/2000 | US6069129 Elastin derived composition and method of using same |
| 05/30/2000 | US6069006 Connective tissue growth factor (CTGF) regulatory nucleic acid sequences |
| 05/30/2000 | US6068983 Introducing into cells a dna molecule coding for an fc receptor which is then expressed for increased phagocytic activity; combating infection and/or modulating immune complex disease |
| 05/30/2000 | US6068845 Inhibitory activity on the abnormal production of extracellular matrices in dermal fibroblasts activated with tranforming growth factor beta by administering the plant extract of a plant belonging to the genus sophora |
| 05/25/2000 | WO2000029620A1 Methods of facilitating vascular growth |
| 05/25/2000 | WO2000029588A1 Lysozyme fusion proteins in infections |
| 05/25/2000 | WO2000029584A1 Antibody variants with higher binding affinity compared to parent antibodies |
| 05/25/2000 | WO2000029583A2 Immunoglobulin superfamily proteins |
| 05/25/2000 | WO2000029574A2 Inflammation-associated genes |
| 05/25/2000 | WO2000029569A1 Methods of diagnosing or treating neurological diseases |
| 05/25/2000 | WO2000029446A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies |
| 05/25/2000 | WO2000029435A1 12 human secreted proteins |
| 05/25/2000 | WO2000029422A1 31 human secreted proteins |
| 05/25/2000 | WO2000029401A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/25/2000 | WO2000029377A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii |
| 05/25/2000 | WO2000029011A1 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 05/25/2000 | WO2000028983A1 Novel 4-dedimethy laminotetra cycline derivatives |
| 05/25/2000 | WO2000028977A1 Antioxidant gel for gingival conditions |
| 05/25/2000 | WO2000019988A8 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF |
| 05/25/2000 | WO2000012049A3 A method for the treatment of staphylococcal disease |
| 05/25/2000 | DE19955793A1 CCR-3-Rezeptor-Antagonisten CCR-3 receptor antagonists |
| 05/25/2000 | DE19853278A1 New 4-amino-2-aryl-cyclopentapyrimidine derivatives are activators of soluble guanylate cyclase, useful for treating or preventing e.g. thrombosis and restenosis |
| 05/25/2000 | CA2350914A1 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 05/25/2000 | CA2350785A1 31 human secreted proteins |
| 05/25/2000 | CA2350722A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii |
| 05/25/2000 | CA2350415A1 Inflammation-associated genes |
| 05/25/2000 | CA2350391A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies |
| 05/25/2000 | CA2349837A1 Lysozyme fusion proteins in infections |
| 05/25/2000 | CA2348824A1 12 human secreted proteins |
| 05/25/2000 | CA2348459A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/25/2000 | CA2347833A1 Antibody variants with higher binding affinity compared to parent antibodies |
| 05/25/2000 | CA2340468A1 Methods of facilitating vascular growth |
| 05/24/2000 | EP1002862A1 Methods of diagnosing or treating neurological diseases |
| 05/24/2000 | EP1002081A2 Delayed progression to aids by a missense allele of the ccr2 gene |
| 05/24/2000 | EP1001976A2 Peptides having potassium channel opener activity |
| 05/24/2000 | EP1001975A1 Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2000 | EP1001974A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2000 | EP1001973A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2000 | EP1001972A1 Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2000 | EP1001971A1 Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2000 | EP1001955A1 1,2,4-triazolo 4,3-b]pyrido 3,2-d]pyridazine derivatives and pharmaceutical compositions containing them |
| 05/24/2000 | EP1001766A1 Compounds and methods |
| 05/24/2000 | EP1001764A1 Heterocyclic amide compounds as cell adhesion inhibitors |
| 05/24/2000 | EP0793674B1 Human neutrophil elastase inhibitors |
| 05/24/2000 | EP0626969B1 CoA-IT AND PAF INHIBITORS |
| 05/24/2000 | CN1254344A Estrogenic 10-Noradnrost-17-one derivatives with aromatic B-ring |
| 05/24/2000 | CN1254341A Pharmaceutically accpetable salts of 3-hydroxy-estr-5-(10)-en-17-one 3-sulphate active as estrogens |
| 05/24/2000 | CN1254335A Nicotinamide derivatives |
| 05/24/2000 | CN1254333A Immunotherapeutic imides/amides |
| 05/24/2000 | CN1253948A Substituted tricyclic compound |
| 05/24/2000 | CN1253810A Medicine for curing chronic bronchitis and its preparation method |
| 05/24/2000 | CN1253806A Medicine for external application for curing rhinitis and its preparation method |
| 05/24/2000 | CN1052725C Tricyclic vasopressin antagonists |
| 05/23/2000 | US6066730 Boronic ester and acid compounds, synthesis and uses |
| 05/23/2000 | US6066717 RsbW-1 protein |
| 05/23/2000 | US6066657 For the treatment of disease states associated with proteins which mediate cellular activity, for example by inhibiting tumor necrosis factor or phosphodiesterase iv |
| 05/23/2000 | US6066641 Phosphodiesterases as molecular targets for anti-asthmatic agents |
| 05/23/2000 | US6066502 Endothelin converting enzyme (ECE) |
| 05/23/2000 | US6066498 Compositions for the treatment and diagnosis of immune disorders |
| 05/23/2000 | US6066322 Administering antibody to treat asthma; treating helper t-cell mediated conditions |